Our Division is focused on excellence in clinical care, education, research, quality improvement, and advocacy related to a broad range of diseases in the diverse fields of pediatric allergy, immunology, and pulmonary medicine.
Our clinical expertise in Allergy and Immunology spans multiple areas that include:
- Allergic rhinitis
- Eczema and atopic dermatitis
- Food allergies
- Immunodeficiency, in the Comprehensive Hematology, Immunology, and Infectious Diseases Program (CHIIP)
- Medication/drug allergy
Clinical research is an important focus of members of the Division. Leonard Bacharier, MD is a physician-scientist whose career is focused on childhood asthma. Donna Hummell, MD and Allison Norton, MD serve as Subject Matter Experts in the CDC Clinical Immunization Safety Assessment (CISA) on COVID-19. Membership in the Food Allergy Research & Education (FARE) Center of Excellence allows us to participate in food allergy research with other centers from across the U.S. Yasmin Khan, MD is a member of the State Genetic Advisory Board and serves as medical advisor for issues related to newborn screening for immunodeficiency. The CHIIP clinic has partnered with the Human Immunology Discovery Initiative (HIDI) through the Vanderbilt Center for Immunology to further immunophenotype patients with diverse immunodeficiences.
The Allergy-Immunology Fellowship Program is sponsored in the Department of Medicine and welcomes pediatric residents interested in fellowship training.
Our clinical expertise in Pulmonary Medicine spans all areas of the discipline, with specific focus on:
- Aerodigestive disorders, including the Complex Aerodigestive Evaluation Team (CADET)
- Bronchopulmonary Dysplasia
- Cystic Fibrosis
- Primary Ciliary Dyskinesia
- Pulmonary Vascular Disease, including Pulmonary Hypertension
- Rare Lung disease
- Sleep Disorders
Our clinical programs have received national recognition, including the Cystic Fibrosis Foundation Quality Award at our most recent CF Program accreditation renewal in 2018. Our Primary Ciliary Dyskinesia (PCD) Center is accredited through the PCD Foundation Clinical and Research Centers Network, and our Pulmonary Hypertension Program is one of only eight pediatric programs in the nation accredited as a Pulmonary Hypertension Comprehensive Care Center.
Our research focus parallels areas of clinical expertise. Eric Austin, MD, MSc and Christian Rosas-Salazar, MD, MPH are dedicated physician-scientists leading translational research programs, and all members of the Division are involved in research activities. We are collaborators on national and international studies, including clinical trials, to facilitate clinical research in BPD, CF, PCD, pulmonary hypertension, and rare lung disease. Our faculty and trainees have obtained competitive grant funding from the National Institutes of Health, and private foundations, and industry.
Our Pediatric Pulmonology fellowship program is dedicated to training the next generation of clinicians and physician-scientists, and graduates of our program practice in academic programs across the country.
Thanks for your interest, and I invite you to learn more about the division through our website and to contact us with questions and interest in collaboration.
Paul E. Moore MD
Professor of Pediatrics and Pharmacology
Division Director, Pediatric Allergy, Immunology, and Pulmonary Medicine